Congress codifies vaccine committee, accelerates new shot approvals
S. 3323 — Family Vaccine Protection Act · Filed by John Hickenlooper (D-CO) · 9 cosponsors · Introduced Dec 3, 2025 · Hearing held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill formally codifies the Advisory Committee on Immunization Practices (ACIP) into federal law, establishing clear procedures for how the committee makes vaccine recommendations, how those recommendations are published, and what happens when federal health officials reject them. It requires HHS to explain any deviation from ACIP recommendations within 48 hours to Congress, and it mandates that the committee consider new vaccines within 90 days of FDA approval. The bill also adds an evidentiary standard to the National Vaccine Injury Compensation Program, requiring that any changes to the list of vaccine-related injuries be supported by scientific evidence. Vaccine manufacturers, health insurers, and healthcare providers stand to benefit from clearer, faster recommendation processes.
Why we flagged it
The bill primarily codifies and strengthens the existing Advisory Committee on Immunization Practices (ACIP) into statute, establishing formal procedures, membership criteria, and transparency requirements. It also adds evidentiary standards to the National Vaccine Injury Compensation Program.
What the text implies
- Codifying ACIP into statute may constrain future executive flexibility in vaccine policy and could create litigation risk if HHS deviates from committee recommendations without meeting the 'preponderance of best available scientific evidence' standard.
- The 48-hour notification requirement to Congress when HHS rejects ACIP recommendations may politicize vaccine decisions by creating a formal congressional review mechanism for what are currently technical health determinations.
The full analysis lists 5 implications of this text.
Who stands to gain
vaccine manufacturers (Pfizer, Moderna, J&J, Merck, etc.); health insurance plans (through expanded vaccine coverage mandates); healthcare providers (through increased immunization administration)